Delivery of Therapeutic Agents Using Oligonucleotide-modified Nanoparticles As Carriers
Disclosed are drug delivery compositions comprising an oligonucleotide-modified nanoparticle and a therapeutic agent. Specifically, disclosed are compositions comprising a number of oligonucleotide molecules in a ratio to therapeutic agent molecules to allow a sufficient transportation of the therapeutic agent molecules into a cell. The therapeutic agents include both hydrophobic and hydrophilic. Different attachments of therapeutic agents in a composition are also described.
Patents:WO 2,011,028,850
Inventor(s):
MIRKIN CHAD A [US]; GILJOHANN DAVID A [US]; DANIEL WESTON L [US]
Type of Offer:
Licensing
« More Life Sciences Patents